欢迎来到天天文库
浏览记录
ID:32863482
大小:1.85 MB
页数:56页
时间:2019-02-16
《加味黄芪建中汤治疗消化性溃疡(脾胃虚寒证)临床疗效观察》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、学位论文加味黄芪建中汤治疗消化性溃疡(脾胃虚寒证)临床疗效观察胡业建指导教师姓名:鋈超主任医师申请学位级别:亟±专业名称:圭医凼型堂论文提交时间:二O一二年五月中文摘要目的:通过加味黄芪建中汤治疗消化性溃疡(脾胃虚寒证)的临床实验研究,观察其临床疗效。方法:将符合诊断标准的50例病人随机分为治疗组和对照组。治疗组患者为25例,对照组患者为25例。两组病例一般资料、治疗前症状积分基本相同,经统计学处理,无显著性差异意义,具有可比性。治疗组以加味黄芪建中汤治疗,对照组治疗以奥美拉唑、阿莫西林、克拉霉素治疗。比较治疗前后的临床症状改善情况。结果:(
2、1)临床症状有效率治疗组为88.00%,对照组为80.00%;胃镜检查的有效率治疗组为92.00%,对照组88.00%。两有效率,治疗组和对照组比较无统计意义(P>0.05)。(2)治疗组和对照组治疗后各症状积分与治疗前组内比较均有统计学意义(P<0.05)。(3)治疗组及对照组的患者在临床研究过程中均未见不良反应。结论:(1)治疗组和对照组总有效率比较无显著性差异。(2)两组治疗方法都能获得较好的临床疗效,加味黄芪建中汤治疗消化性溃疡疗效并不低于西药(奥美拉唑、阿莫西林、克拉霉素)。关键词:消化性溃疡,加味黄芪建中汤,奥美拉唑,阿莫西林,克
3、拉霉素ABSTRACTobjective:ThroughmodifiedHuangqijianzhongDecoctioninthetreatmentofpepticulcer(spleendeficiencysyndrome)intheclinicalexperimentalresearch,toobserveitsclinicalcurativeeffectMethods:Willmeetthecriteriaforthediagnosisof50caseswererandomlydividedintotreatmentgroupandc
4、ontrolgroup.Patientsinthetreatmentgroupof25cases,25casesofpatientsofcontrolgroup.Generalmaterialsoftwogroupsbeforetreatment,symptomscoresarebasicallythesame,statistically,therewasnosignificantdifferenceinmeaning,withcomparable.ThetreatmentgroupweretreatedwithmodifiedHuangqi
5、jianzhongSouptreatment,grouptherapywithomeprazole,amoxicillin,clarithromycintherapy.Beforeandalterthetreatment,theclinicalsymptomimprovement.Results:(1):tClinicalsymptomsofefficiencyinthetreatmentgroupWas88%,80%incontrolgroup;gastroscopyandtheefficiencyot92%inthetreatmentgr
6、oup,controlgroup88%.Twoefficiency,thetreatmentgroupandthecontrolgrouphadnostatisticalsignificance(P>O.05).(2):Thetreatmentgroupandcontrolgroupaftertreatmentthesymptomscoresandbeforetreatmentwithingroupcomparisonswerestatisticallysignificant(P7、ntrolgroupofpatientsinclinicalcourseofstudyshowednoadversereaction.Conclusion:(1):Thetreatmentgroupandthecontrolgroupinthetotalefficiencyofnosignificantdifferencecompared(2):ThetwogroupsoftreatmentCangetbetterclinicalefficacy,modifiedHuangqijianzhongDecoctioninthetreatmento8、fpepticulcerefficacyislowerthanWesternMedicine(omeprazole,amoxiciUin,clarithromyci
7、ntrolgroupofpatientsinclinicalcourseofstudyshowednoadversereaction.Conclusion:(1):Thetreatmentgroupandthecontrolgroupinthetotalefficiencyofnosignificantdifferencecompared(2):ThetwogroupsoftreatmentCangetbetterclinicalefficacy,modifiedHuangqijianzhongDecoctioninthetreatmento
8、fpepticulcerefficacyislowerthanWesternMedicine(omeprazole,amoxiciUin,clarithromyci
此文档下载收益归作者所有